DAWN Stock Analysis: Buy, Sell, or Hold?
DAWN - Day One Biopharmaceuticals, Inc. Common Stock
$11.16
0.00 (0.00%)
▲
HOLD
LOW Confidence
Last Updated: January 30, 2026
Earnings: Feb 24, 2026
23d
Get Alerted When DAWN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: DAWN shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: DAWN shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: DAWN is currently trading at $11.16, which is considered slightly high relative to its 30-day fair value range of $9.14 to $11.62.
Technical Outlook: Technically, DAWN is in a strong uptrend. Immediate support is located at $9.84, while resistance sits at $13.20.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $23.56 (+111.1%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, DAWN is in a strong uptrend. Immediate support is located at $9.84, while resistance sits at $13.20.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $23.56 (+111.1%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Fair Price Range
$9.14 -
$11.62
Company Quality Score
60/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
66.8%
Protect Your Profits
Holding DAWN? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- NEUTRAL: Mixed technical signals (55/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 111.1% below Wall St target ($23.56)
- CAUTION: Recommendation downgraded due to -6.6% 5-day decline
Fair Price Analysis
30-Day Fair Range
$9.14 -
$11.62
Current vs Fair Value
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$9.84
Resistance Level
$13.20
Current Trend
Strong Uptrend
Fundamental Context
Forward P/E (Next Year Est.)
-20.55
Wall Street Target
$23.56
(+111.1%)
Revenue Growth (YoY)
-57.6%
Profit Margin
-113.5%
Last updated: January 30, 2026 9:43 PM ET
Data refreshes hourly during market hours. Next update: 10:43 PM
Data refreshes hourly during market hours. Next update: 10:43 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is DAWN showing a specific setup today?
Insider Activity (6 Months)
0
Buys
4
Sells
Net
INSIDERS SELLING
Recent Transactions
Adam Dubow
SELL
4365 shares
2025-08-18
Charles N York II
SELL
4106 shares
2025-08-18
Jeremy Bender
SELL
16058 shares
2025-08-18
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VRTX
Vertex Pharmaceuticals I… |
BUY
34 analysts |
$500 | 62 BUY |
|
INSM
Insmed Inc |
STRONG BUY
19 analysts |
$214 | 60 BUY |
|
CYTK
Cytokinetics Inc |
STRONG BUY
21 analysts |
$89 | 61 BUY |
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$64 | 55 HOLD |
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
18 analysts |
$216 | 53 HOLD |
Advanced DAWN Option Strategies
Professional options setups generated by AI based on today's DAWN price and gamma walls.
